Any DNA to Declare? Regulating Offshore Access to Genetic Enhancement


This Article begins by briefly addressing in Part II why GE should receive special consideration from a theoretical perspective in light of the many other biotechnologies that have raised concern. In Part III, it explores the multiple forms that GE might take and delineates the threats GE poses to the United States. Part IV analyzes traditional methods of enforcement used both in the United States and abroad that might apply to GE regulation. Part V discusses the difficulties in enforcing such restrictions in the United States and abroad. Finally, Part VI concludes that while a completely effective ban on offshore access to GE is improbable, the United States should still strive to regulate GE abroad because of the threats it presents to society.



Publication Date


Document Type


Place of Original Publication

American Journal of Law & Medicine

Publication Information

28 American Journal of Law and Medicine 179 (2002)

This document is currently not available here.


COinS Maxwell J. Mehlman Faculty Bio